参考文献/References:
[1]Kolominsky-Rabas PL, Weber M, Gefeller O, et al. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study [J]. Stroke, 2001, 32(12): 2735-2740.
[2]Cole TS, Mezher AW, Catapano JS, et al. Nationwide trends in carotid endarterectomy and carotid artery stenting in the post-CREST era [J]. Stroke, 2020, 51(2): 579-587.
[3]Sussman ES, Jin M, Pendharkar AV, et al. Dual antiplatelet therapy after carotid artery stenting: trends and outcomes in a large national database [J]. J Neurointerv Surg, 2021, 13(1): 8-13.
[4]Noubiap JJ, Agbaedeng TA, Tochie JN, et al. Meta-analysis comparing the frequency of carotid artery stenosis in patients with atrial fibrillation and vice versa [J]. Am J Cardiol, 2021, 138: 72-79.
[5]Lopes RD, Heizer G, Aronson R, et al. Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation [J]. N Engl J Med, 2019, 380(16): 1509-1524.
[6]Sgarbossa EB, Pinski SL, Barbagelata A, et al. Electrocar-diographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block: GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) Investigators [J]. N Engl J Med, 1996, 334(8): 481-487.
[7]Lehtola H, Airaksinen KEJ, Hartikainen P, et al. Stroke recurrence in patients with atrial fibrillation: concomitant carotid artery stenosis doubles the risk [J]. Eur J Neurol, 2017, 24(5): 719-725.
[8]Lip GY, Windecker S, Huber K, et al. Management of anti-thrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS) [J]. Eur Heart J, 2014, 35(45): 3155-3179.
[9]Cannon CP, Bhatt DL, Oldgren J, et al. Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation [J]. N Engl J Med, 2017, 377(16): 1513-1524.
[10]Ugurlucan M, Akay HT, Erdinc I, et al. Anticoagulation strategy in patients with atrial fibrillation after carotid endarterectomy [J]. Acta Chir Belg, 2019, 119(4): 209-216.
[11]Douros A, Renoux C, Yin H, et al. Concomitant use of direct oral anticoagulants with antiplatelet agents and the risk of major bleeding in patients with nonvalvular atrial fibrillation [J]. Am J Med, 2019, 132(2): 191-199.
[12]Anand SS, Bosch J, Eikelboom JW, et al. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial [J]. Lancet, 2018, 391(10117): 219-229.
相似文献/References:
[1]张鹏飞 赵立文 汪子文 唐 铸 赵文可 何一川 杨俊丽 于耀宇.内膜斑块剥脱术与支架置入术治疗颈动脉狭窄的Meta分析[J].中国临床神经外科杂志,2016,(08):455.[doi:10.13798/j.issn.1009-153X.2016.08.003]
ZHANG Peng-fei,ZHAO Li-wen,WANG Zi-wen,et al.Endarterectomy versus stenting for carotid artery stenosis: a meta-analysis of randomized controlled clinical trials[J].,2016,(10):455.[doi:10.13798/j.issn.1009-153X.2016.08.003]
[2]郑铁晋 阚志生 史今盛.老年颈内动脉狭窄血压变化及与脑卒中的关系[J].中国临床神经外科杂志,2016,(08):485.[doi:10.13798/j.issn.1009-153X.2016.08.014]
[3]宋 平 陈晓斌 杜 浩 蔡 强 罗 明 阮 航 吴京雷 段发亮.内膜斑块剥脱术治疗颈动脉狭窄的临床分析[J].中国临床神经外科杂志,2016,(09):527.[doi:10.13798/j.issn.1009-153X.2016.09.006]
SONG Ping,CHEN Xiao-bin,DU Hao,et al.Clinical analysis of carotid endarterectomy for ischemic stroke[J].,2016,(10):527.[doi:10.13798/j.issn.1009-153X.2016.09.006]
[4]李利彪 陈冬梅 郭春燕 于建设 韩志强.颈动脉内膜斑块剥脱术中颈动脉阻断对局部脑氧饱和度的影响[J].中国临床神经外科杂志,2016,(09):530.[doi:10.13798/j.issn.1009-153X.2016.09.007]
LI Li-biao,CHEN Dong-mei,GUO Chun-yan,et al.Effects of temporary carotid artery occlusion on regional cerebral oxygen saturation during carotid endarterectomy[J].,2016,(10):530.[doi:10.13798/j.issn.1009-153X.2016.09.007]
[5]董 辉 张 晖 蔡 磊 叶权亿 刘 波.颈动脉内膜斑块剥脱术治疗体会[J].中国临床神经外科杂志,2017,(08):587.[doi:10.13798/j.issn.1009-153X.2017.08.023]
[6]姚江伟 李 芸 李树国 姬 翔 赵 博 高 波 赵同源.支架成形术联合弹簧圈栓塞治疗颅外颈动脉狭窄合并颅内动脉瘤[J].中国临床神经外科杂志,2017,(11):771.[doi:10.13798/j.issn.1009-153X.2017.11.012]
[7]苑万众 综述 王 涛 审校.颈动脉内膜斑块切除术对颈动脉狭窄病人认知功能影响的研究进展[J].中国临床神经外科杂志,2019,(12):774.[doi:10.13798/j.issn.1009-153X.2019.12.021]
[8]观龙彬 综述 黄书岚 审校.颈动脉狭窄手术方式和手术时机的研究进展[J].中国临床神经外科杂志,2020,(08):569.[doi:10.13798/j.issn.1009-153X.2020.08.024]
[9]向春晖 潘 轲 田仁富 舒孟仙.颈动脉内膜斑块剥脱术治疗支架内再狭窄1例[J].中国临床神经外科杂志,2020,(08):575.[doi:10.13798/j.issn.1009-153X.2020.08.028]
[10]刘花艳 陈太丽 张卫兵.三维超声检查在评估CEA后再狭窄中的作用[J].中国临床神经外科杂志,2021,26(02):68.[doi:10.13798/j.issn.1009-153X.2021.02.002]
LIU Hua-yan,CHEN Tai-li,ZHANG Wei-bing.Value of three-dimensional ultrasound in evaluation of restenosis after carotid endarterectomy[J].,2021,26(10):68.[doi:10.13798/j.issn.1009-153X.2021.02.002]